Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Neuronal Cell Death in TBI
NCT00260052Phase 3Withdrawn
- Sponsor
- Medical College of Wisconsin
- Start
- Jul 2003
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of erythropoietin in traumatic brain injury (TBI), sponsored by Medical College of Wisconsin. Planned start Jul 2003; status: withdrawn.
02
Drugs
erythropoietin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00260052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260052.